Stephen Crawford
Listed on 1 Form D filing across 1+ issuer
· Director
Associated issuers
- Hexamer Therapeutics, Inc CIK 1797915 · WA
Filings (1)
-
Hexamer Therapeutics, IncD · Sep 15, 2026 · WA · Biotechnology$2.5MView filing →